Joseph K. Belanoff - Significant Ownership

Location
Menlo Park, CA
Summary
This page shows a list of all the recent SCHEDULE 13D/G filings made by Joseph K. Belanoff.

Notify me when Joseph K. Belanoff files a new Schedule 13D/G report.

⭐ Subscribe ⭐

Significant Ownership of Joseph K. Belanoff

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
CORT Corcept Therapeutics Incorporated Common Stock 6.3% $541M 6.82M Joseph K. Belanoff Dec 31, 2024

Schedules 13D/G Reported by Joseph K. Belanoff:

Sym Target Class Ownership Change Current Shares Change Value Reporting name Form Report Period Date Filed
* An asterisk sign (*) next to the price indicates that the price is likely invalid.